(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5(Date:10/8/2008)...rogram to evaluate TAXUS(R) Element(TM) Platinum C...TICK, Mass., Oct. 8 /- Bost...unced that it has completed enrollment in,the PERS...d-generation,TAXUS(R) Element(TM) paclitaxel-eluti...s enrolled nearly 1,500 patients at 100 U.S. and,i...
(Date:10/7/2008)...Oct. 7 /- McLaren Health Care and its...f the world,s leading medical,minds to share the l...,gastrointestinal cancer treatments. The October 1...anized by McLaren,s Sukamal Saha, M.D., an,award-w...node mapping for,colorectal cancer has gained worl...
(Date:10/7/2008)...azotide Acetate Prevented Immunologic Changes Indu...iac Disease, Additional Data Indicates Potential i...la., Oct. 7 /- Alba Therapeutics Corp...s this week at the American,College of Gastroenter...rom,study CLIN 1001-004, the first Phase IIa trial...
(Date:10/7/2008)...s., Oct. 7 /- Taligen Therapeutics In... the Company,s pipeline,candidates were presented ...asel, Switzerland. The data highlighted the candid...ent-mediated diseases., "These highlighted presen...nted at the conference, reveal the deep expertise ...
Breaking Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Trana Discovery and Southern Research Institute Announce the First RNA RNA High Throughput Drug Screening Assay Platform for HIV Antivirals 287 1Trana Discovery and Southern Research Institute Announce the First RNA RNA High Throughput Drug Screening Assay Platform for HIV Antivirals 287 2Trana Discovery and Southern Research Institute Announce the First RNA RNA High Throughput Drug Screening Assay Platform for HIV Antivirals 287 3Trana Discovery and Southern Research Institute Announce the First RNA RNA High Throughput Drug Screening Assay Platform for HIV Antivirals 287 4FDA Approves LEVAQUIN 28R 29 Short Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis 1438 1FDA Approves LEVAQUIN 28R 29 Short Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis 1438 2FDA Approves LEVAQUIN 28R 29 Short Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis 1438 3FDA Approves LEVAQUIN 28R 29 Short Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis 1438 4Penn engineers design computer memory in nanoscale form that retrieves data 1 000 times faster 629 1Penn engineers design computer memory in nanoscale form that retrieves data 1 000 times faster 629 2Penn engineers design computer memory in nanoscale form that retrieves data 1 000 times faster 629 3AUDIO from Medialink and Pfizer 3A A New Prescription for Safer Drugs 1435 1...n 5, 2007 - Gloucester,Pharmaceuticals, Inc., a pr...ny, today announced that data for romidepsin as a,... peripheral,T-cell lymphoma (PTCL) were presented ...) Annual Meeting being held in Chicago, IL.,The da...phase II,study of romidepsin sponsored by the Nati...
...Newswire-FirstCall/ --,Alexza Pharmaceuticals, Inc... Annual NCDEU Meeting the results of a Phase I cli...s being developed for,the treatment of acute agita...DEU meeting is co-sponsored by the National Instit...linical,Psychopharmacology. , The poster presentat...
Other Medicine Technology:Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting 2Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting 3Alexza Pharmaceuticals to Present AZ-004 (Staccato Loxapine),Clinical Data at the Annual NCDEU Meeting 2Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923, a gram negative control of Escherichia coli ATCC ® 25922 and areas for three clinical specimens. Ideal for s
...e Equalizer With 384 Well Plate Capability The E...es of the original Equalizerexpandable and equal t...lavable components, and in-lab calibration capabil...y space your tips down to 4.5mm for loading and ac...
...p Expandable Tip System A lower cost alternative ...to perform multi-sample transfers between two diff... of a knob, tip spacing can be quickly and easily ...) or 96 well plates. Ergonomic Design for Unparal...
...p Expandable Tip System A lower cost alternative ...to perform multi-sample transfers between two diff... of a knob, tip spacing can be quickly and easily ...) or 96 well plates. Ergonomic Design for Unparal...
Medicine Products: